| 000 | 01198 a2200313 4500 | ||
|---|---|---|---|
| 005 | 20250514231714.0 | ||
| 264 | 0 | _c20060126 | |
| 008 | 200601s 0 0 eng d | ||
| 022 | _a0923-7534 | ||
| 024 | 7 |
_a10.1093/annonc/mdi307 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aEngert, A | |
| 245 | 0 | 0 |
_aRecombinant human erythropoietin in oncology: current status and further developments. _h[electronic resource] |
| 260 |
_bAnnals of oncology : official journal of the European Society for Medical Oncology _cOct 2005 |
||
| 300 |
_a1584-95 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Review; Systematic Review | ||
| 650 | 0 | 4 |
_aAnemia _xdrug therapy |
| 650 | 0 | 4 | _aEconomics, Pharmaceutical |
| 650 | 0 | 4 |
_aErythropoietin _xeconomics |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aNeoplasms _xcomplications |
| 650 | 0 | 4 | _aPrognosis |
| 650 | 0 | 4 | _aRecombinant Proteins |
| 650 | 0 | 4 | _aRisk Factors |
| 650 | 0 | 4 | _aSurvival |
| 650 | 0 | 4 |
_aThrombosis _xetiology |
| 773 | 0 |
_tAnnals of oncology : official journal of the European Society for Medical Oncology _gvol. 16 _gno. 10 _gp. 1584-95 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1093/annonc/mdi307 _zAvailable from publisher's website |
| 999 |
_c15617539 _d15617539 |
||